Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Cleveland, OH
NPI: 1104960525Primary Practice Location
UH REGIONAL HOSPITALS
27100 Chardon Rd, Richmond Heights, OH
Primary Employer
University Hospitals Medical Group Inc
uhhospitals.org
HQ Phone
Get M.D. Prateek's Phone Numberphone_androidMobile
Get M.D. Prateek's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardSC State Medical License
OH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 147 | 244 |
| 2 | 99442Physician telephone patient service, 11-20 minutes of medical discussion | 43 | 63 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 42 | 59 |
| 4 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 13 | 17 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 11 | 26 |
Organ Preservation for Recurrent Urethral Adenocarcinoma With Concurrent Chemotherapy and Radiation.
Targeted Next-Generation Sequencing in Men with Metastatic Prostate Cancer: a Pilot Study.
Authors: Petros Grivas
Journal: Target Oncol
Authors: Ahmad Tarhini
Publication Date: 2018-07-04
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Docetaxel, OTHER: Laboratory Biomarker Analysis, RADIATION: External Beam Radiation Therapy, DRUG: Degarelix, DRUG: Bicalutamide, DRUG: Flutamide, DRUG: Goserelin Acetate, DRUG: Leuprolide Acetate, DRUG: Leuprolide, DRUG: Goserelin, DRUG: Nilutamide
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, DRUG: Prednisone, DRUG: Antiandrogen Therapy, DRUG: Cabazitaxel, DRUG: Abiraterone Acetate, PROCEDURE: Orchiectomy
Lead Sponsor: University Hospitals Cleveland Medical Center
Intervention / Treatment: OTHER: COVID antibody titers in the blood
